BioSpace News Archive

BioMidwest

KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)

Renalytix plc announces that the KidneyIntelX In-Vitro Diagnostic test has been included in the final KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, published on March 13, 2024.

March 14, 2024
·
9 min read
Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing

Pluri Inc. announced that its CDMO division has signed a manufacturing agreement with Remedy Cell Ltd, an innovative, biopharmaceutical company developing stem cell-derived, cell-free therapeutics for complex fibrotic conditions.

March 14, 2024
·
5 min read
Pharm Country

Calder Biosciences Inc. Publishes Next-Generation Vaccine Technology in Nature Communications

Calder Biosciences, Inc ., a next-generation vaccine company, has been published in a Nature Communications article (https://www.nature.com/articles/s41467-024-46295-8 ) that debuts and validates the application of Calder’s ‘3D Vaxlock’ platform technology.

March 14, 2024
·
2 min read
Biotech Bay

Agilent Presents 2024 Darlene Solomon Award to University of Cambridge Researcher Joycelyn Tan

Agilent Technologies Inc. announced that Joycelyn Tan, a Ph.D. student at the Wellcome-MRC Institute of Metabolic Science at the University of Cambridge, UK, has been awarded the 2024 Darlene Solomon Award.

March 14, 2024
·
3 min read
Lone Star Bio

Form Bio Helps Life Sciences Professionals Transform Omics Data Into Breakthrough Insights Through Google Cloud

Form Bio , the breakthrough computational life sciences solutions provider, today announced the availability of Google Cloud’s innovative AI-based models for healthcare and life sciences research as point-and-click workflows via Form Bio’s bioinformatics platform.

March 14, 2024
·
5 min read
NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering Event

NLS Pharmaceutics Ltd. today announced that Alex Zwyer, Chief Executive Officer of NLS Pharmaceutics will attend the BIO-EUROPE Springtime Partnering Event taking place March 18-20, 2024.

March 14, 2024
·
1 min read
Business

IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024*

IPA (IMMUNOPRECISE ANTIBODIES LTD.) today reported financial results for its third quarter of the 2024 fiscal year (“FY24”), which ended January 31, 2024.

March 14, 2024
·
8 min read
Lone Star Bio

New KDIGO Guideline Supports Genetic Testing for the Majority of CKD Patients to Establish Cause of Disease

Natera, Inc., a global leader in cell-free DNA testing, commented on the 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, which was recently published by the Kidney Disease Improving Global Outcomes organization, a leading medical society in nephrology.

March 14, 2024
·
4 min read
Business

Endeavor BioMedicines Appoints Enoch Kariuki, Pharm.D. as President and Vishaal Turakhia as Chief Financial Officer

Endeavor BioMedicines today announced the appointment of Enoch Kariuki, Pharm.D. as President and Vishaal Turakhia as Chief Financial Officer (CFO).

March 14, 2024
·
3 min read
Pharm Country

GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics

GeneDx today announced its scientific contributions at the 2024 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting.

March 14, 2024
·
4 min read